Business Description
GRAIL Inc
NAICS : 541380
SIC : 2835
ISIN : US3847471014
Total Employee Number:
910Description
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 9.44 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.24 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.89 | |||||
Beneish M-Score | -2.09 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 30.8 | |||||
3-Year EBITDA Growth Rate | 18.4 | |||||
3-Year EPS without NRI Growth Rate | 23.7 | |||||
3-Year FCF Growth Rate | 24.3 | |||||
3-Year Book Growth Rate | -24.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 1.91 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 24.93 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.55 | |||||
9-Day RSI | 51.36 | |||||
14-Day RSI | 51.26 | |||||
3-1 Month Momentum % | 22.86 | |||||
6-1 Month Momentum % | -23.16 | |||||
12-1 Month Momentum % | 126.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.95 | |||||
Quick Ratio | 10.74 | |||||
Cash Ratio | 10.31 | |||||
Days Inventory | 29.97 | |||||
Days Sales Outstanding | 40.19 | |||||
Days Payable | 7.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.1 | |||||
Shareholder Yield % | 0.09 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -31.31 | |||||
Operating Margin % | -323.02 | |||||
Net Margin % | -236.95 | |||||
EBITDA Margin % | -229 | |||||
FCF Margin % | -179.33 | |||||
OCF Margin % | -178.47 | |||||
ROE % | -16.08 | |||||
ROA % | -14.11 | |||||
ROIC % | -19.54 | |||||
3-Year ROIIC % | -12.1 | |||||
ROC (Joel Greenblatt) % | -471.97 | |||||
ROCE % | -19.79 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 17.11 | |||||
PB Ratio | 1.24 | |||||
Price-to-Tangible-Book | 4.13 | |||||
EV-to-EBIT | -4.49 | |||||
EV-to-Forward-EBIT | -3.98 | |||||
EV-to-EBITDA | -6.33 | |||||
EV-to-Revenue | 14.48 | |||||
EV-to-Forward-Revenue | 13.38 | |||||
EV-to-FCF | -7.95 | |||||
| Price-to-Net-Current-Asset-Value | 5.12 | |||||
| Price-to-Net-Cash | 5.61 | |||||
Earnings Yield (Greenblatt) % | -22.3 | |||||
FCF Yield % | -9.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GRAIL Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 142.136 | ||
| EPS (TTM) (€) | -8.383 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 109.91 | ||
| 14-Day RSI | 51.26 | ||
| 14-Day ATR (€) | 3.302214 | ||
| 20-Day SMA (€) | 60.139 | ||
| 12-1 Month Momentum % | 126.14 | ||
| 52-Week Range (€) | 26.7 - 99.8 | ||
| Shares Outstanding (Mil) | 44.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GRAIL Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GRAIL Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-19 17:00 | In 185 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-19 | In 184 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-12 16:30 | In 86 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 85 days | ||
| Canaccord Genuity 46th Annual Growth Conference | 2026-08-11 10:00 | 59.64 (+0.40%) | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 16:30 | 62.78 (+3.91%) | ||
| Second quarter earnings results for 2026 | 2026-08-05 | 62.78 (+3.91%) | ||
| General meeting for 2026 | 2026-06-18 16:00 | 51.58 (+3.12%) | ||
| Goldman Sachs 47th Annual Global Healthcare Conference | 2026-06-09 11:20 | 52.44 (+4.01%) | ||
| Guidance call for 2026 | 2026-06-03 07:35 | 51.16 (-5.99%) |
Show
Entries
GRAIL Inc Frequently Asked Questions
What is GRAIL Inc(STU:NL0)'s stock price today?
The current price of STU:NL0 is €60.76. The 52 week high of STU:NL0 is €99.80 and 52 week low is €26.70.
When is next earnings date of GRAIL Inc(STU:NL0)?
The next earnings date of GRAIL Inc(STU:NL0) is 2026-11-12 Est..
Does GRAIL Inc(STU:NL0) pay dividends? If so, how much?
GRAIL Inc(STU:NL0) does not pay dividend.
Press Release
Articles on GRAIL Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers